April 18, 2021 Breaking News, Latest News, and Videos

UCLA: “Turbocharged Artificial Intelligence” Could Personalize Pediatric Leukemia Treatment

UCLA team’s digital health platform is capable of optimizing efficacy and safety during chemotherapy.

A team of UCLA bioengineers has demonstrated that its technology may go a long way toward overcoming the challenges of treatment for acute lymphoblastic leukemia, among the most common types of cancer in children, and has the potential to help doctors personalize drug doses.

mother holding child's hand who have IV solution in the hospital
mother holding child’s hand who have IV solution in the hospital

The five-year survival rate for individuals with pediatric acute lymphoblastic leukemia is about 85 percent, however those who experience a recurrence generally have a poor prognosis and a bone marrow transplant is their only option for a permanent cure.

Conventional treatment for this leukemia includes a combination of drugs, which come with short- and long-term side effects. Two
of these drugs, 6-mercaptopurine and methotrexate, can cause liver disease and other life-threatening infections. During the maintenance phase of treatment, which aims to keep individuals in remission, dosing for these two drugs is frequently adjusted through a system of trial and error, which is not always accurate.

The UCLA team from the Schools of Dentistry, Medicine and Engineering showed that its digital health technology platform, called Phenotypic Personalized Medicine, or PPM, can surmount the treatment challenges for this leukemia. The technology platform is based on the team’s stunning discovery that a patient’s physical response to drug treatment, such as tumor size or bacterial and viral levels in the blood, could be visually represented in the shape of a parabola, or U-shaped line. The graphs plot the drug dose along the horizontal axis and the patient’s response to treatment on the vertical axis.

The technology has the ability to accurately identify a person’s optimal drug and dose combinations throughout an entire course of treatment. In addition, the technology platform does not require any complex and expensive analysis of a patient’s genetic information or the biological basis of the disease, greatly accelerating the ability to optimize and personalize care.

The team’s findings appear online in the peer-reviewed journal SLAS Technology, which features innovations in technology for drug development and diagnostics.

“Phenotypic Personalized Medicine is like turbocharged artificial intelligence. It personalizes combination therapy to optimize efficacy and safety,” said Dean Ho, co-corresponding author of the study and professor of oral biology and medicine. “The ability for our technology to continuously pinpoint the proper dosages of multiple drugs from such a large pool of possible combinations overcomes a challenge that is substantially more difficult than finding a needle in a haystack,” added Ho, who is also the co-director of the Weintraub Center for Reconstructive Biotechnology at the UCLA School of Dentistry.

In this study, patient records were obtained on the dosing of 6-mercaptopurine and methotrexate, as well as on the corresponding absolute neutrophil count, or levels of a subset of white blood cells called neutrophils that are vital for staving off potentially life-threatening infections. These records showed multiple instances where conventional chemotherapy doses caused deviations from acceptable neutrophil levels. Using the personalized medicine technology, individualized three-dimensional maps were generated to determine the optimal 6-mercaptopurine/methotrexate drug ratios.

The team members found that their technology-suggested drug dosages were as much as 40 percent lower compared to clinical chemotherapy dosages, while still maintaining target neutrophil levels. The parabolas showed that markedly different dosages of each drug were required to maintain normal white blood cell counts for each patient. Their results demonstrated a clear need to personalize acute lymphoblastic leukemia treatment, and will serve as a foundation for a pending clinical trial to optimize multi-drug chemotherapy.

“PPM has the ability to personalize combination therapy for a wide spectrum of diseases, making it a broadly applicable technology,” said Chih-Ming Ho, distinguished research professor of mechanical and aerospace engineering and co-corresponding author of the study. “The fact that we don’t need any information pertaining to a disease’s biological process in order to optimize and personalize treatment is a revolutionary advance. We’re at the interface of digital health and cancer treatment.”

Dr. Vivian Chang, co-first author of the study and assistant professor of pediatrics and hematology and oncology, said, “Optimizing combination therapy for [pediatric leukemia] on a patient-specific level would be a game-changer for the way that this cancer, as well as many other cancers, is addressed. Reducing side effects while maintaining or even enhancing efficacy could also improve the long-term treatment outcomes of our patients.” Chang is also co-director of the Pediatric Cancer Predisposition Clinic at UCLA.

The research team is planning to recruit patients for a prospective trial within the next year. The technology is approved for additional infectious disease and oncology studies.

Other authors of the study, all from UCLA, are co-first author and postdoctoral researcher Dong-Keun Lee and graduate student Theodore Kee. Dean Ho, Chih-Ming Ho and Chang are also members of the Jonsson Comprehensive Cancer Center.

This work was supported by the National Cancer Institute, National Science Foundation, V Foundation for Cancer Research, Wallace H. Coulter Foundation, Society for Laboratory Automation and Screening, UCLA Children’s Discovery and Innovation Institute, Today’s and Tomorrow’s Children Fund Award and the endowment fund of the Ben Rich–Lockheed Martin Professorship.

Tags: , in News
Related Posts

Edify TV: $2 Billion Beverly Hills Development Proposed Near Westside

April 16, 2021

April 16, 2021

A developer wants to build a $2 billion condo and retail development flanking the Beverly Hilton hotel. Learn more in...

State Funds Two Additional Sustainable Housing Proposals in Santa Monica

April 16, 2021

April 16, 2021

Proposals are designed to help with affordability and sustainability  By Toi Creel California is paving the way for environmentally-friendly housing...

Santa Monica City Council Rejects Proposed Ban of Certain Items at Protests

April 15, 2021

April 15, 2021

Lawmakers vote down item 4-3 at meeting this week  By Sam Catanzaro  Santa Monica lawmakers rejected a motion this week...

Edify TV: LAFD Announces Likely Cause of Ballona Wetlands Fire

April 15, 2021

April 15, 2021

The LAFD has revealed the cause of a March fire that destroyed five acres of the Ballona Wetlands. Learn more...

Shake Shack Set to Open in Santa Monica

April 15, 2021

April 15, 2021

NYC-based burger chain to open at Wilshire and 5th this weekend By Kerry Slater East Coast burger joint Shake Shack...

Restaurant Spotlight: Piccolo Bringing Fine Italian Dining to Santa Monica and Venice

April 15, 2021

April 15, 2021

Latest restaurant from Chef Antonio Mure with two locations on Westside  By Timothy Michael An esteemed chef with deep ties...

Edify TV: Venice Handball Courts Encampment Cleared

April 15, 2021

April 15, 2021

Sanitation crews Thursday cleared a homeless encampment at the Venice Beach handball courts. Learn more in this video made possible...

ArcLight Cinema Santa Monica Closing

April 14, 2021

April 14, 2021

Pacific Theatres will not reopen locations across country due to pandemic  By Sam Catanzaro  The 12-screen ArcLight Cinema complex in...

Westside Cafe Helping Save Monarch Butterflies

April 13, 2021

April 13, 2021

This Westside cafe is doing its part to keep its namesake insect, the monarch butterfly, safe. Learn more in this...

Junior Lifeguards Returning This Summer

April 13, 2021

April 13, 2021

County-run program returns to LA County beaches July and August  By Sam Catanzaro A few weeks are left for prospective...

Earth Day Beach Cleanup at Santa Monica Beach

April 13, 2021

April 13, 2021

Santa Monica Travel & Tourism organizing April 22 event  On Earth Day next week join a “micro-cleanup” to help beautify...

Six Vendors Released on Citation for Fight at Santa Monica Pier

April 12, 2021

April 12, 2021

Santa Monica police cite and release six people involved in Sunday incident By Sam Catanzaro Six individuals were released on...

City Council Passes New Measure to Meet State Affordable Housing Mandate: Santa Monica Beat – April, 12, 2021

April 12, 2021

April 12, 2021

Local news and culture in under 5 minutes. * City Council Passes New Measure to Meet State Affordable Housing Mandate...